Page 44 - SPEMD_61-3
P. 44

134                    rev port estomatol med dent cir maxilofac. 2020;61(3):128-134


             pediatric patients: an updated review for general dental   19. Ponce -Torres E, Ruíz -Rodríguez MS, Alejo -González F,
             practitioner. Mater Sociomed. 2015;27:359 -62.      Hernández -Sierra JF, Pozos -Guillén AJ. Oral manifestations in
           10. Freitas de Morais EF, Lira JAS, Macedo RAP, Santos KS, Elias   pediatric patients receiving chemotherapy for acute
             CTV, Morais MLSA. Oral manifestations resulting from   lymphoblastic leukemia. J Clin Pediatr Dent. 2010;34:275 -9.
             chemotherapy in children with acute lymphoblastic   20. Ritwik P. Dental Care for Patients With Childhood Cancers.
             leucemia. Braz J Otorhinolaryngol. 2014.80:78 -85.  Ochsner J. 2018;18:351 -7.
           11. Javed F, Utreja A, Bello Correa FO, Al -Askar M, Hudieb M,   21. Parra JJ, Alvarado MC, Monsalve P, Costa ALF, Montesinos GA,
             Qayyum F, Al -Rasheed A, Almas K, Al -Hezaimi K. Oral health   Parra PA. Oral health in children with acute lymphoblastic
             status in children with acute lymphoblastic leucemia. Crit   leukaemia: before and after chemotherapy treatment. Eur
             Rev Oncol Hematol. 2012;83:303 -9.                  Arch Paediatr Dent. 2020;21:129 -36.
           12. Dental Management of Pediatric Patients Receiving   22. Aggarwal A, Pai KM. Orofacial Manifestations of Leukemic
             Immunosuppressive Therapy and/or Radiation Therapy. In:   Children on Treatment: A Descriptive Study. Int J Clin Pediatr
             American Academy of Pediatric Dentistry. Oral Health   Dent. 2018;11:193 -8.18.
             Policies & Recommendations (The Reference Manual of   23. Lula ECO, Lula CEO, Alves CM, Lopes FF, Pereira AL.
             Pediatric Dentistry). 2019 -2020:422 -430. [Disponível em:   Chemotherapy -induced oral complications in leukemic
             https://www.aapd.org/research/oral -health -policies–  patients. Int J Pediatr Otorhinolaryngol. 2007;71:1681 -5.
             recommendations/dental -management -of -pediatric-  24. Paiva -Neto GO. Leucemia linfoblástica de células B (LLL -B):
             -patients -receiving -Immunosuppressive -therapy -andor-  incidência de agravos bucais e índices hematológicos em
             -radiation -therapy/ – Acedido em 02/01/2020].      pacientes pediátricos em tratamento pelo protocolo GBTLI
           13. Cuschieri S. The STROBE guidelines. Saudi J Anaesth.   LLA -2009. Dissertação. (Programa de Pós -Graduação em
             2019;13(Suppl 1):S31 -S34.                          Odontologia) – Universidade Federal do Amazonas, Manaus.
           14. Ministério da Saúde, 2006. Serviços Odontológicos. Prevenção   2018.
             e Controle de Riscos. Agência Nacional de Vigilância   25. Mendonça RM, Araújo Md, Levy CE, Morari J, Silva RA, Yunes
             Sanitária, Brasil: Brasília; 2006. [Disponível em: http://www.  JA, et al. Oral Mucositis in Pediatric Acute Lymphoblastic
             anvisa.gov.br/servicosaude/manuais/manual_odonto.pdf –   Leukemia Patients: Evaluation of Microbiological and
             Acedido em 02/01/2020]                              Hematological Factors. Pediatr Hematol Oncol. 2015;32:322-
           15. World Health Organization. Handbook for Reporting Results   -30.
             of Cancer Treatment. World Health Organization,   26. Kamasaki Y, Satoh K, Nishiguchi M, Hoshino T, Fujiwara T.
             Switzerland: Geneva, 1979. [Disponível em: https://apps.who.  Acute oral complications in a pediatric patient with acute
             int/iris/handle/10665/37200 – Acedido em 01 -06 -2019]  lymphoid leukemia. Pediatr Int. 2016;58:484 -7.
           16. Gandhi K, Datta G, Ahuja S, Saxena T, G Datta A. Prevalence   27. Oliveira JMS, Pereira JV, Lira EC, Santos CMB, Paiva -Neto GO,
             of Oral Complications occurring in a Population of Pediatric   Libório -Kimura TN. Evaluation of the buccal mucosa of
             Cancer Patients receiving Chemotherapy. Int J Clin Pediatr   patients with acute lymphocytic leukemia: A case series
             Dent. 2017;10:166 -71.                              study. Rev Port Estomatol Med Dent Cir Maxilofac.
           17. Garrocho -Rangel JA, Herrera -Moncada M, Márquez -Preciado   2019;60:163 -8.
             R, Tejeda -Nava F, Ortiz -Zamudio JJ, Pozos -Guillén A. Oral   28. Ribeiro ILA, Limeira RRT, Dias de Castro R, Ferreti Bonan PR,
             mucositis in paediatric acute lymphoblastic leukemia   Valença AMG. Oral Mucositis in Pediatric Patients in
             patients receiving methotrexate -based chemotherapy: case   Treatment for Acute Lymphoblastic Leukemia. Int J Environ
             series. Eur J Paediatr Dent. 2018;19:239 -42.       Res Public Health. 2017;14:1468.
           18. Mendonça RMH, de Araújo M, Levy CE, Morari J, Silva RA,   29. Padmini C, Bai KY. Oral and Dental Considerations in
             Yunes JA, et al. Prospective evaluation of HSV, Candida spp.,   Pediatric Leukemic Patient. ISRN Hematol. 2014;2014:895721.
             and oral bacteria on the severity of oral mucositis in   30. Subramaniam P, Babu KL, Nagarathna J. Oral Manifestations
             pediatric acute lymphoblastic leukemia. Support Care   In Acute Lymphoblastic Leukemic Children Under
             Cancer. 2012;20:1101 -7.                            Chemotherapy. J Clin Pediatr Dent. 2008;32:319 -24.
   39   40   41   42   43   44   45   46   47   48   49